Search research articles
Contact Us
Filters
Showing results (181-190 of 286) with videos related to
Page
of 29
Sort By:
Oncogene
|
September 17, 2013
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer
L Du, Z Zhao, X Ma, et al.
The Journal of Clinical Investigation
|
August 1, 1986
Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene
B E Johnson, J Battey, I Linnoila, et al.
Genes, Chromosomes & Cancer
|
September 18, 1997
Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines
S T Ong, K M Fong, S A Bader, et al.
International Journal of Immunopathology and Pharmacology
|
April 10, 2010
Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer
H Imai, N Sunaga, Y Shimizu, et al.
The American Journal of Pathology
|
July 1, 1988
A study of myc-related gene expression in small cell lung cancer by in situ hybridization
J Gu, R I Linnoila, N L Seibel, et al.
Cancer Research
|
June 1, 1985
Establishment and identification of small cell lung cancer cell lines having classic and variant features
D N Carney, A F Gazdar, G Bepler, et al.
Cancer Research
|
September 1, 1986
Glycolipid antigen expression in human lung cancer
S L Spitalnik, P F Spitalnik, C Dubois, et al.
Oncogene
|
April 9, 2008
DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers
W W Lockwood, R Chari, B P Coe, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1988
Monoclonal antibodies for the in vitro detection of small cell lung cancer metastases in human bone marrow
A M Lebacq-Verheyden, A Neirynck, A M Ravoet, et al.
Cancer Treatment Reports
|
December 1, 1984
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness
G Morstyn, G P Schechter, D C Ihde, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 286) with videos related to
Sort By:
Page
of 29
Oncogene
|
September 17, 2013
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer
L Du, Z Zhao, X Ma, et al.
The Journal of Clinical Investigation
|
August 1, 1986
Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene
B E Johnson, J Battey, I Linnoila, et al.
Genes, Chromosomes & Cancer
|
September 18, 1997
Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines
S T Ong, K M Fong, S A Bader, et al.
International Journal of Immunopathology and Pharmacology
|
April 10, 2010
Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer
H Imai, N Sunaga, Y Shimizu, et al.
The American Journal of Pathology
|
July 1, 1988
A study of myc-related gene expression in small cell lung cancer by in situ hybridization
J Gu, R I Linnoila, N L Seibel, et al.
Cancer Research
|
June 1, 1985
Establishment and identification of small cell lung cancer cell lines having classic and variant features
D N Carney, A F Gazdar, G Bepler, et al.
Cancer Research
|
September 1, 1986
Glycolipid antigen expression in human lung cancer
S L Spitalnik, P F Spitalnik, C Dubois, et al.
Oncogene
|
April 9, 2008
DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers
W W Lockwood, R Chari, B P Coe, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1988
Monoclonal antibodies for the in vitro detection of small cell lung cancer metastases in human bone marrow
A M Lebacq-Verheyden, A Neirynck, A M Ravoet, et al.
Cancer Treatment Reports
|
December 1, 1984
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness
G Morstyn, G P Schechter, D C Ihde, et al.
Page
of 29